Actively Recruiting
Pilot Study on the Correlation Between Accelerations Experienced
Led by Sys2Diag · Updated on 2026-04-09
66
Participants Needed
1
Research Sites
156 weeks
Total Duration
On this page
Sponsors
S
Sys2Diag
Lead Sponsor
C
Centre National de la Recherche Scientifique, France
Collaborating Sponsor
AI-Summary
What this Trial Is About
Concussion, or mild traumatic brain injury, accounts for 85% of brain injuries and is common in both professional and amateur sports. It results from kinetic impacts causing a temporary disruption of brain function, often without visible abnormalities on imaging, making diagnosis difficult. The majority of concussions remain undetected, without specific management. To facilitate detection, the development of reliable salivary BMs is essential, as they offer a non-invasive, rapid, and simple method for early identification of biological changes related to concussions.
CONDITIONS
Official Title
Pilot Study on the Correlation Between Accelerations Experienced
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Male subject
- Subject aged between 19 and 20 years
- Subject willing to follow the study procedures
- Subject capable of understanding the purpose, nature, and methodology of the study
- Subject affiliated with a French social security scheme or a beneficiary of such a scheme
- Subject who has signed the non-opposition to participation in the research
- Subject who has signed the informed consent for salivary micro-RNA analysis
- Subject selected in the French under-20 rugby team (U20).
You will not qualify if you...
- Subject not affiliated with a French Social Security scheme or not a beneficiary of such a scheme
- Subject deprived of liberty, protected adults, vulnerable persons, or minors
- Subject with proven or suspected chronic infectious disease that may pose a risk of contamination during sample handling
- Subject suffering from Gougerot-Sj�f6gren syndrome (dry syndrome)
- Refusal to sign the non-opposition
- Refusal to sign the informed consent for salivary micro-RNA analysis
- Subject who has suffered a recent stroke or epileptic event (within the last two months)
- Subject suffering from neurological diseases.
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Sys2Diag - Umr9005 Cnrs/Alcen
Montpellier, France, 34184
Actively Recruiting
Research Team
W
Wendpouiré A OUEDRAOGO, MSc
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
1
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here